Paul Baverel

Senior Director Clinical Pharmacology (radioligand Therapy And T-cell Engagers) at Molecular Partners

Paul Baverel, PhD, serves as Senior Director of Clinical Pharmacology at Molecular Partners, specializing in dosing optimization for T-cell engagers and radioligand therapies. With extensive experience in clinical pharmacology, pharmacometrics, and drug development, Paul previously held leadership roles at Roche, MedImmune, and Eli Lilly, managing teams and guiding decision-making processes across oncology and virology pipelines. Paul possesses a strong educational background with multiple degrees, including a PhD in Pharmacometrics from Uppsala University, and a Postgraduate Diploma in Entrepreneurship from Cambridge Judge Business School. Professional contributions include the regulatory approval of biologic projects and the development of innovative modeling strategies that have advanced drug candidates through various development phases.

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices